Eden Research
Eden Research plc

Eden Research plc share price, company news, analysis and interviews

Eden Research plc (LON:EDEN) is an AIM-quoted company focussed on sustainable biopesticides and plastic-free encapsulation technology for the use in global crop protection, animal health and consumer products industries. 

CROP PROTECTION

Biological solutions are the fastest growing segment of the crop protection industry, and Eden is the only UK-listed company with a focus on this market with proven products and a growing business.

Eden’s plant protection products are derived from natural plant chemistry and suitable for a wide range of crops. Used on high-value fruits and vegetables, the product’s efficacy and regulatory status make them ideally suited to solve the challenges faced by growers in today’s increasingly tough regulatory climate.

A key characteristic of Eden’s products is that they are exempt from pesticide residue limits and can be used up to the point of harvest, giving flexibility and security to growers. 

ANIMAL HEALTH

In 2020 the global animal health market value is estimated to exceed $33 billion.

Terpenes are well-known as effective treatments for a range of pathogens that affect animal health.

Organisms associated with skin conditions and ear infections can be effectively treated by one or more terpenes. However, upon encapsulation, these same terpenes are generally more effective due to their increased bioavailability and persistence, which is achieved through sustained release.

Steady progress has been made with four products: a shampoo, a conditioner, a spray and an oticetic flush.

CONSUMER PRODUCTS

Sustaine® has applications in the human health sector where natural chemistries are sought after. Key markets include oral care, human haircare, deodrants and headlice. Eden’s associate, TerpeneTech, has developed and is commercialising its headlice formulation in the UK and USA.

Human Health

TerpeneTech, which is an associate of Eden through Eden’s shareholding of 29.9%, has been preparing the launch of its headlice treatment product.

Biocides

Eden’s encapsulated terpene products are highly effective biocides.

Eden Research
Eden Research
Eden Research

Share this page

Eden Research

Eden Research plc share price

Fundamentals

52 Week High / Low

News

Eden Research

Eden Research Plc granted numerous US state regulatory approvals

Eden Research plc (LON:EDEN; OTCQB: EDNSF), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, has announced today that it has to date received regulatory approval in 17 US states for its formulated product Mevalone®, and 8 US states for its formulated product Cedroz™. These approvals follow regulatory authorisation from the United States Environmental Protection Agency (EPA) in September 2022 for all six petitions submitted by Eden (three active ingredients, two formulated products and Eden’s Sustaine® polymer-free encapsulation technology; making up the building blocks of current and future products), opening

Eden Research

Eden Research flagship biofungicide, Mevalone authorisation for domestic use

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, has announced that its flagship biofungicide, Mevalone®, has received authorisation for home garden use in Italy for the control of a number of important plant pathogens affecting the home grower.  The diseases include Botrytis cinerea and powdery mildew, destructive fungal pathogens affecting many plant species. Mevalone, which is marketed as 3LOGY® in Italy, is already approved for agricultural use across a wide range of crops including: wine and table grapes, tomatoes, apple, pears, strawberries, cucumber, and many

Eden Research Plc

Eden Research CEO Sean Smith “2022 has been a productive year”

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, has provided the following unaudited trading update for the year ended 31 December 2022. Highlights ·      Revenue for the year is expected to have increased by approximately 50% to ÂŁ1.8m, ÂŁ0.1m, or 6%, ahead of market expectations of ÂŁ1.7m (FY2021: ÂŁ1.2m) ·      Product sales are expected to have increased by approximately 55% to ÂŁ1.7m, ÂŁ0.3m, or 21%, ahead of market expectations of ÂŁ1.4m (FY2021: ÂŁ1.1m) ·      Loss before tax is expected to be approximately ÂŁ2.8m, ÂŁ0.3m, or 10%, ahead of

Eden Research Plc

Eden Research signs distribution agreement with with Corteva France

Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that it has signed an agreement with Corteva France which allows Corteva to market, distribute and sell Eden’s fungicide product, Mevalone®, in France on an exclusive basis.   Mevalone is Eden’s flagship, sustainable, foliar biofungicide, which is used to treat Botrytis cinerea on grapes and various other crops, a fungal disease commonly found in crops exposed to humid conditions. Eden also recently received authorisation for the use of Mevalone on pome fruits, including apples and pears, in France

Interviews

Question & Answers

Analyst Notes & Comments

More Information

Latest Eden Research plc News

Interviews

Questions & Answers

Broker Notes & Comments

Eden Research plc share price

Fundamentals

Share this page

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.